Temodar offers promise for treating astrocytomas.
Temodar is an exciting new drug that shows promise in the treatment of brain tumors as well as in other types of cancers. Research currently is being conducted with Temodar to determine its efficacy in treating various solid tumors, glioblastoma multiform, and even metastatic melanoma. Temodar provides adult patients with anaplastic astrocytoma with another option of therapy that is convenient, produces minimal side effects, and, above all, instills hope.
Emory University, 1365 Clifton Road NE, Suite B6222 South Clinic, Atlanta, GA 30322, USA. Terri_Armstrong@emory.org
T
T
Armstrong
C
C
Hancock
D000465:Algorithms; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D001254:Astrocytoma / Q000188:drug therapy*; D001932:Brain Neoplasms / Q000097:blood / Q000188:drug therapy*; D003606:Dacarbazine / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D003663:Decision Trees; D004334:Drug Administration Schedule; D016903:Drug Monitoring; D006801:Humans; D007958:Leukocyte Count; D009504:Neutrophils; D010353:Patient Education as Topic; D010976:Platelet Count; D000077204:Temozolomide; D016896:Treatment Outcome
D018906:Antineoplastic Agents, Alkylating; D003606:Dacarbazine; D000077204:Temozolomide